nimodipine has been researched along with Nervous System Diseases in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (27.78) | 18.7374 |
1990's | 5 (27.78) | 18.2507 |
2000's | 1 (5.56) | 29.6817 |
2010's | 6 (33.33) | 24.3611 |
2020's | 1 (5.56) | 2.80 |
Authors | Studies |
---|---|
Bacila, A; Buongarzone, G; Canavero, I; Coloberti, E; Costa, A; Fiamingo, G; Gastaldi, M; Ghiotto, N; Ravaglia, S | 1 |
Anand, S; Goel, G; Gupta, V | 1 |
Brüning, R; Ehlert, A; Heindel, W; Hesselmann, V; Jacobs, AH; Manthei, G; Pluta, RM; Ringelstein, EB; Schmidt, C; Stummer, W; Wölfer, J | 1 |
Bridgeman, MB; Dalal, KS | 1 |
Chen, B; Cheng, MH; Fan, BS; Shi, HQ; Tian, JS; Yu, JG; Zhang, Y | 1 |
Ni, J; Wang, C; Wang, X; Yang, Y | 1 |
Amenta, F; Lanari, A; Silvestrelli, G; Tomassoni, D; Traini, E | 1 |
de Oliveira, GH; Emerick, GL; Peccinini, RG | 1 |
Michenfelder, JD; Milde, JH; Newberg, LA; Steen, PA | 1 |
Fisher, M; Jonas, S; Jones S [corrected to Jonas, S]; Sacco, RL | 1 |
Cambria, RA; Gloviczki, P; Lowell, RC; Okazaki, H; Rhee, RY | 1 |
Mazzarella, V; Zivin, JA | 1 |
Clark, WM; Madden, KP; Marcoux, FW; Probert, AW; Rivier, J; Weber, ML; Zivin, JA | 1 |
Bogaert, MG; Buylaert, WA; Calle, PA; De Ridder, L | 1 |
Heiskanen, O; Ohman, J | 1 |
Adams, HP; Biller, J; Godersky, JC | 1 |
Hillman, J; Johansson, I; Leszniewski, W; von Essen, C | 1 |
Allen, GS | 1 |
4 review(s) available for nimodipine and Nervous System Diseases
Article | Year |
---|---|
HaNDL syndrome: a reversible cerebral vasoconstriction triggered by an infection? A case report and a case-based review.
Topics: Adult; Albumins; Calcium Channel Blockers; Epstein-Barr Virus Nuclear Antigens; Headache; Humans; Immunoglobulin G; Immunoglobulin M; Lymphocytosis; Male; Nervous System Diseases; Nimodipine; Syndrome; Vasoconstriction; Vasospasm, Intracranial | 2022 |
Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies.
Topics: Animals; Calcium Channel Blockers; Cerebrovascular Disorders; Controlled Clinical Trials as Topic; Disease Models, Animal; Humans; Nervous System Diseases; Nimodipine | 2008 |
Prophylactic neuroprotection for cerebral ischemia.
Topics: Cerebrovascular Disorders; Coronary Artery Bypass; Endarterectomy, Carotid; Humans; Ischemic Attack, Transient; N-Methylaspartate; Nervous System Diseases; Nimodipine; Randomized Controlled Trials as Topic | 1994 |
Cerebral arterial spasm.
Topics: Blood Platelets; Calcium; Cerebral Arterial Diseases; Humans; Muscle Contraction; Nervous System Diseases; Nicotinic Acids; Nimodipine; Receptors, Serotonin; Recurrence; Serotonin; Spasm; Subarachnoid Hemorrhage | 1985 |
1 trial(s) available for nimodipine and Nervous System Diseases
Article | Year |
---|---|
Timing of operation for ruptured supratentorial aneurysms: a prospective randomized study.
Topics: Adolescent; Adult; Aged; Brain Ischemia; Circle of Willis; Evaluation Studies as Topic; Humans; Intracranial Aneurysm; Middle Aged; Nervous System Diseases; Nimodipine; Prospective Studies; Random Allocation; Rupture, Spontaneous; Subarachnoid Hemorrhage; Time Factors | 1989 |
13 other study(ies) available for nimodipine and Nervous System Diseases
Article | Year |
---|---|
Continuous intra-arterial dilatation with nimodipine and milrinone for refractory cerebral vasospasm.
Topics: Angioplasty, Balloon; Cerebral Angiography; Dilatation; Drug Resistance; Female; Humans; Infusions, Intravenous; Middle Aged; Milrinone; Nervous System Diseases; Nimodipine; Subarachnoid Hemorrhage; Vasodilator Agents; Vasospasm, Intracranial | 2014 |
Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Infarction; Brain Ischemia; Drug Therapy, Combination; Female; Follow-Up Studies; Hemodynamics; Humans; Male; Middle Aged; Molsidomine; Nervous System Diseases; Nimodipine; Prospective Studies; Stroke; Subarachnoid Hemorrhage; Tomography, X-Ray Computed; Treatment Outcome; Vasodilator Agents; Vasospasm, Intracranial; Young Adult | 2016 |
Neurologic and psychiatric medications.
Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Cyclopropanes; Dibenzazepines; Drug Therapy; Humans; Mental Disorders; Milnacipran; Nervous System Diseases; Nimodipine | 2015 |
Sodium Sulfide, a Hydrogen Sulfide-Releasing Molecule, Attenuates Acute Cerebral Ischemia in Rats.
Topics: Acute Disease; Analysis of Variance; Animals; Apoptosis; Aspirin; Blood Pressure; Cell Survival; Cells, Cultured; Cerebrovascular Circulation; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Electroencephalography; Fibrinolytic Agents; Heart Rate; Infarction, Middle Cerebral Artery; Mice; Mice, Inbred C57BL; Nervous System Diseases; Neuroprotective Agents; Nimodipine; Rats; Rats, Sprague-Dawley; Sulfides; Time Factors | 2016 |
New monocyte locomotion inhibitory factor analogs protect against cerebral ischemia-reperfusion injury in rats.
Topics: Animals; Brain Ischemia; Calcium Channel Blockers; Infarction, Middle Cerebral Artery; Interleukin-1beta; Male; Molecular Weight; Nervous System Diseases; Neuroprotective Agents; Nimodipine; Oligopeptides; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tumor Necrosis Factor-alpha | 2017 |
Organophosphorus-induced delayed neuropathy: a simple and efficient therapeutic strategy.
Topics: Animals; Calcium; Calcium Channels; Calcium Gluconate; Carboxylic Ester Hydrolases; Chickens; Disease Models, Animal; Homeostasis; Muscles; Nervous System Diseases; Nimodipine; Pesticides; Tritolyl Phosphates | 2010 |
Cerebral blood flow and neurologic outcome when nimodipine is given after complete cerebral ischemia in the dog.
Topics: Animals; Blood Gas Analysis; Blood Pressure; Brain Ischemia; Calcium Channel Blockers; Cerebrovascular Circulation; Dogs; Drug Administration Schedule; Hemoglobins; Nervous System Diseases; Nicotinic Acids; Nimodipine; Oxygen | 1984 |
The effects of nimodipine on ischemic injury of the spinal cord during thoracic aortic cross-clamping.
Topics: Animals; Aorta, Thoracic; Calcium Channel Blockers; Constriction; Dogs; Hyperemia; Laser-Doppler Flowmetry; Nervous System Diseases; Nimodipine; Reperfusion Injury; Spinal Cord; Time Factors | 1996 |
Tissue plasminogen activator plus glutamate antagonist improves outcome after embolic stroke.
Topics: Animals; Cerebrovascular Disorders; Dizocilpine Maleate; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Glutamic Acid; Intracranial Embolism and Thrombosis; Nervous System Diseases; Nimodipine; Rabbits; Tissue Plasminogen Activator | 1991 |
Treatment with conotoxin, an 'N-type' calcium channel blocker, in neuronal hypoxic-ischemic injury.
Topics: Animals; Calcium; Calcium Channel Blockers; Cells, Cultured; Hypoxia; Injections; Ischemia; Ketamine; Nervous System Diseases; Nimodipine; omega-Conotoxin GVIA; Peptides, Cyclic; Rabbits; Spinal Cord; Subarachnoid Space | 1990 |
Nimodipine has no beneficial effect on neurological outcome in a cardiopulmonary arrest model in the rat.
Topics: Animals; Blood Pressure; Cell Survival; Coronary Disease; Disease Models, Animal; Electrocardiography; Heart Arrest; Hippocampus; Male; Nervous System Diseases; Nimodipine; Psychomotor Performance; Rats; Rats, Inbred Strains; Resuscitation | 1990 |
Management of aneurysmal subarachnoid hemorrhage.
Topics: Aminocaproic Acid; Humans; Intracranial Aneurysm; Nervous System Diseases; Nicardipine; Nimodipine; Recurrence; Subarachnoid Hemorrhage | 1988 |
Significance of "ultra-early" rebleeding in subarachnoid hemorrhage.
Topics: Female; Hematoma; Humans; Intracranial Aneurysm; Male; Mental Disorders; Middle Aged; Nervous System Diseases; Nimodipine; Recurrence; Rupture, Spontaneous; Subarachnoid Hemorrhage; Time Factors | 1988 |